What's Going On With Candel Therapeutics Stock?

on MSN ago, source:

Candel Therapeutics, Inc. (NASDAQ:CADL) shares are trading higher Thursday after the company received FDA orphan drug ...

Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag

7d ago, source: Zacks.com on MSN

Candel Therapeutics, Inc. CADL announced that the FDA has granted orphan drug designation to its lead investigational ...

Candel Therapeutics: CAN-2409 May Go Beyond Scope Of Targeting Pancreatic Cancer

4d ago, source:

Candel Therapeutics, Inc. has done well to advance its main drug CAN-2409 for the treatment of patients with several types of ...

Retail investors invested in Candel Therapeutics, Inc. (NASDAQ:CADL) up 320% last week, insiders too were rewarded

13d ago, source:

While retail investors were the group that reaped the most benefits after last week’s 320% price gain, insiders also received ...

Candel Therapeutics Inc CADL

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Candel Therapeutics stock soars 30%: find out more

14d ago, source:

Last week, the Nasdaq-listed firm reported $11.1 million loss for its fourth quarter more than double the $4.1 million it ...

Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors

10d ago, source:

First-in-class multimodal immunotherapy candidate, for induction of tertiary lymphoid structures, being developed as a novel ...

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer

8d ago, source:

We recently reported data from the phase 2 randomized clinical trial of CAN-2409 in borderline resectable pancreatic cancer, showing that CAN-2409, when added to standard of care, more than doubled ...

Candel Therapeutics stock jumps as pancreatic cancer treatment shows promise

15d ago, source: Morningstar

Results come after Candel downsized to focus on core assets Shares of Candel Therapeutics Inc. (CADL) climbed 15% early Friday after the company released new data from a trial of its experimental ...

Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights

22d ago, source: Business Insider

March 28, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...

Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer

15d ago, source: Nasdaq

NEEDHAM, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal ...

Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag

7d ago, source: Nasdaq

Candel Therapeutics, Inc. CADL announced that the FDA has granted orphan drug designation to its lead investigational adenovirus immunotherapy candidate, CAN-2409, for the treatment of pancreatic ...